What is the recommended antibiotic regimen and duration for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Cellulitis

First-Line Antibiotic Selection

For typical nonpurulent cellulitis, prescribe an oral antibiotic active against streptococci (penicillin, amoxicillin, cephalexin, dicloxacillin, or clindamycin) for 5 days. 1

Standard Nonpurulent Cellulitis

  • Oral options for streptococcal coverage include: 1

    • Penicillin
    • Amoxicillin
    • Cephalexin (500 mg four times daily) 2
    • Dicloxacillin
    • Amoxicillin-clavulanate
    • Clindamycin
  • These agents target β-hemolytic streptococci, which are the predominant pathogens in typical cellulitis 1, 3

  • MRSA is an unusual cause of typical cellulitis and routine coverage is unnecessary 1

Cellulitis Requiring MRSA Coverage

Add MRSA-active antibiotics only if specific risk factors are present: 1

  • Penetrating trauma or injection drug use
  • Purulent drainage present
  • Evidence of MRSA infection elsewhere or nasal colonization
  • Systemic inflammatory response syndrome (SIRS)

Oral MRSA-active options include: 1

  • Trimethoprim-sulfamethoxazole (TMP-SMX) 1, 4
  • Doxycycline or minocycline 1
  • Clindamycin (covers both streptococci and MRSA) 1, 4
  • Linezolid 600 mg twice daily 1

For dual streptococcal and MRSA coverage: 1

  • Clindamycin alone, OR
  • TMP-SMX or doxycycline PLUS a β-lactam (amoxicillin or cephalexin)

Note that TMP-SMX combined with cephalexin was no more effective than cephalexin alone for pure cellulitis without purulent features 1


Treatment Duration

The recommended duration is 5 days if clinical improvement has occurred by day 5. 1

Extension Criteria

  • Extend treatment beyond 5 days only if the infection has not improved 1, 5
  • Look for reduction in erythema, warmth, tenderness, swelling, and resolution of fever 5
  • Continue the same antibiotic if it was appropriate for the suspected pathogen 5
  • Total duration should be guided by clinical response, typically not exceeding 10-14 days 1, 3

A 5-day course is as effective as 10 days when clinical improvement occurs by day 5 1, 6. The IDSA guideline provides strong evidence (high quality) supporting this shorter duration 1


Hospitalized Patients with Complicated Cellulitis

For severe cellulitis requiring hospitalization, use IV antibiotics with MRSA coverage: 1

  • Vancomycin 1 g IV every 12 hours 1
  • Linezolid 600 mg IV/PO every 12 hours 1, 7
  • Daptomycin 4 mg/kg IV once daily 1
  • Telavancin 10 mg/kg IV once daily 1

Duration for complicated infections: 7-14 days 1


Adjunctive Measures

Address predisposing factors to prevent recurrence: 1, 5

  • Elevate the affected extremity 1
  • Examine interdigital toe spaces for fissuring, scaling, or maceration 1, 5
  • Treat underlying conditions: edema, obesity, eczema, venous insufficiency, toe web abnormalities 1, 5

Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in nondiabetic adults 1


When to Hospitalize

Admit patients with: 1

  • SIRS, altered mental status, or hemodynamic instability
  • Concern for deeper or necrotizing infection
  • Failure of outpatient treatment 5
  • Severe immunocompromise 5
  • Poor adherence anticipated

Common Pitfalls

  • Do not routinely obtain cultures for typical cellulitis without systemic signs 1
  • Reserve blood cultures for patients with malignancy, neutropenia, severe immunodeficiency, immersion injuries, or animal bites 1
  • Avoid empiric MRSA coverage in typical nonpurulent cellulitis without risk factors, as β-lactams succeed in 96% of cases 1
  • Do not use rifampin as monotherapy or adjunctive therapy for cellulitis 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Guideline

Management of Unresolved Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.